Citigroup Inc Takeda Pharmaceutical CO LTD Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Citigroup Inc holds 27,513 shares of TAK stock, worth $410,493. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,513

Previous 54,259 49.29%

Holding current value

$410,493

Previous $753,000 52.72%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$12.6 - $13.67 $336,999 - $365,617	-26,746 Reduced 49.29%	27,513 $356,000
Q1 2024 May 10, 2024	BUY	$13.89 - $15.04 $87,270 - $94,496	6,283 Added 13.1%	54,259 $753,000
Q4 2023 Feb 09, 2024	SELL	$13.36 - $15.43 $133,132 - $153,759	-9,965 Reduced 17.2%	47,976 $684,000
Q3 2023 Nov 09, 2023	BUY	$15.03 - $16.32 $46,427 - $50,412	3,089 Added 5.63%	57,941 $896,000
Q2 2023 Aug 10, 2023	BUY	$15.57 - $17.11 $20,007 - $21,986	1,285 Added 2.4%	54,852 $861,000
Q1 2023 May 11, 2023	BUY	$15.28 - $16.48 $37,222 - $40,145	2,436 Added 4.76%	53,567 $882,000
Q4 2022 Feb 09, 2023	SELL	$12.42 - $15.62 $11,066 - $13,917	-891 Reduced 1.71%	51,131 $798,000
Q3 2022 Nov 10, 2022	SELL	$12.8 - $28.65 $11,302 - $25,297	-883 Reduced 1.67%	52,022 $674,000
Q2 2022 Aug 10, 2022	SELL	$13.12 - $15.03 $176,188 - $201,837	-13,429 Reduced 20.24%	52,905 $743,000
Q1 2022 May 12, 2022	SELL	$13.54 - $15.35 $105 Million - $119 Million	-7,723,759 Reduced 99.15%	66,334 $950,000
Q4 2021 Feb 10, 2022	BUY	$13.17 - $16.4 $64.8 Million - $80.7 Million	4,920,375 Added 171.46%	7,790,093 $106 Million
Q3 2021 Nov 10, 2021	BUY	$16.3 - $17.26 $46.8 Million - $49.5 Million	2,869,718 New	2,869,718 $47 Million

Others Institutions Holding TAK

# of Institutions

318

Shares Held

70.4M

Call Options Held

939K

Put Options Held

233K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $46.4B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account